LUM-201-01 – A multicentre, 6-month, randomised, open-label, active control, parallel arm, Phase 2B study of daily oral LUM-201 in Naïve-to-Treatment, prepubertal children with Growth Hormone Deficiency (GHD)

  • Bergman, Philip (Primary Chief Investigator (PCI))
  • Brown, Justin (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date25/05/21 → 24/05/26

Keywords

  • phase 2 study
  • treatment efficacy
  • growth disorders